Devnath, L.; Janzen, I.; Ho, C.; Melosky, B.; Lam, S.; MacAulay, C.; Yuan, R. Fusion of Clinical and Deep Learning Features for Predicting Pembrolizumab Monotherapy Response in Advanced Non-Small Cell Lung Cancer. J. Clin. Med. 2026, 15, 4536. https://doi.org/10.3390/jcm15124536

AMA Style

Devnath L, Janzen I, Ho C, Melosky B, Lam S, MacAulay C, Yuan R. Fusion of Clinical and Deep Learning Features for Predicting Pembrolizumab Monotherapy Response in Advanced Non-Small Cell Lung Cancer. Journal of Clinical Medicine. 2026; 15(12):4536. https://doi.org/10.3390/jcm15124536

Chicago/Turabian Style

Devnath, Liton, Ian Janzen, Cheryl Ho, Barbara Melosky, Stephen Lam, Calum MacAulay, and Ren Yuan. 2026. "Fusion of Clinical and Deep Learning Features for Predicting Pembrolizumab Monotherapy Response in Advanced Non-Small Cell Lung Cancer" Journal of Clinical Medicine 15, no. 12: 4536. https://doi.org/10.3390/jcm15124536

APA Style

Devnath, L., Janzen, I., Ho, C., Melosky, B., Lam, S., MacAulay, C., & Yuan, R. (2026). Fusion of Clinical and Deep Learning Features for Predicting Pembrolizumab Monotherapy Response in Advanced Non-Small Cell Lung Cancer. Journal of Clinical Medicine, 15(12), 4536. https://doi.org/10.3390/jcm15124536

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Statistics

For more information on the journal statistics, click here.

Multiple requests from the same IP address are counted as one view.

Article Menu

Article Versions Notes

Further Information

Guidelines

MDPI Initiatives

Follow MDPI